SCHEMBL8103383

SCHEMBL8103383

CCCOc1nc(OCCC)n(Cc2ccc(Cc3cccc(-c4nnn[nH]4)c3)cc2)n1

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 1/20 0.33
TLR7 Q9NYK1 3/20 0.31
ALDH1A1 P00352 1/20 0.31
TLR8 Q9NR97 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8109235 0.95 TLR7 (0.34) TLR7TLR8
SCHEMBL8103625 0.91 PDE5A (0.32) PDE5AALDH1A1
SCHEMBL8103400 0.86 AGTR1 (0.34) TLR7TLR8
SCHEMBL8105347 0.83 PDE5A (0.35) PDE5ATLR7ALDH1A1TLR8
SCHEMBL8109435 0.83 AGTR1 (0.39) PDE5AALDH1A1
SCHEMBL8095651 0.82 LMNA (0.32)
SCHEMBL8096149 0.79 TLR7 (0.36) TLR7
SCHEMBL8109185 0.78 AGTR1 (0.42)
SCHEMBL8095671 0.76 AGTR1 (0.42)
SCHEMBL8111259 0.76 TP53 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-3098772-B2 2000-10-16 JP claimed
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP claimed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO claimed
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP disclosed
US-5098920-A Hypotensive agents and treatment of congestive heart failure G. D. SEARLE & CO. (US) 1992-03-24 US disclosed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO disclosed